Free Trial

Enlivex Therapeutics (ENLV) Institutional Ownership

Enlivex Therapeutics logo
$0.96 +0.00 (+0.20%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Enlivex Therapeutics (NASDAQ:ENLV)

Current
Institutional Ownership
Percentage
1.02%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$3.43M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$413.37K
Get ENLV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enlivex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ENLV Institutional Buying and Selling by Quarter

Enlivex Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2025 Jane Street Group LLC80,759$78K0.0%+527.4%0.341%
5/15/2025 Armistice Capital LLC1,781,931$1.73M0.0%-19.3%7.534%
2/17/2025 Millennium Management LLC633,847$742K0.0%N/A2.961%
2/14/2025 Two Sigma Securities LLC22,362$26K0.0%N/A0.104%
2/13/2025 Renaissance Technologies LLC158,992$186K0.0%+112.6%0.743%
10/23/2024 Sigma Investment Counselors Inc.30,000$50K0.0%N/A0.140%
8/15/2024 Armistice Capital LLC1,700,571$2.42M0.0%N/A8.148%
8/12/2024 XTX Topco Ltd24,820$35K0.0%N/A0.119%
5/1/2023 Compagnie Lombard Odier SCmA65,000$225K0.0%+30.0%0.350%
2/9/2023 Group One Trading L.P.13,499$53K0.0%+2,689.0%0.073%
7/11/2022 ARK Investment Management LLC331,001$1.66M0.0%-23.8%1.802%
4/27/2022 Compagnie Lombard Odier SCmA50,000$279K0.0%+16.3%0.273%
4/20/2022 Belvedere Trading LLC14,473$101K0.0%-13.9%0.079%
4/19/2022 ARK Investment Management LLC434,343$2.43M0.0%+24.3%2.372%
2/9/2022 Compagnie Lombard Odier SCmA43,000$247K0.0%+22.9%0.235%
2/3/2022ACT Capital Management LLC25,000$156K0.1%-69.7%0.137%
1/28/2022 ARK Investment Management LLC349,308$2.18M0.0%-23.7%1.908%
1/21/2022Golden Green Inc.19,967$125K0.1%-54.7%0.109%
11/12/2021 Renaissance Technologies LLC87,989$869K0.0%-55.0%0.481%
10/28/2021 Compagnie Lombard Odier SCmA35,000$353K0.0%+40.0%0.191%
10/8/2021Golden Green Inc.44,085$436K0.3%-4.2%0.241%
8/13/2021 Renaissance Technologies LLC195,706$1.74M0.0%-32.6%1.242%
8/11/2021 Banque Cantonale Vaudoise10,000$89K0.0%N/A0.063%
8/5/2021 ARK Investment Management LLC514,807$4.58M0.0%+8.1%3.267%
7/17/2021Golden Green Inc.46,020$410K0.3%-34.1%0.292%
5/18/2021 Jane Street Group LLC11,070$123K0.0%N/A0.070%
5/17/2021 Edmond DE Rothschild Holding S.A.13,000$144K0.0%N/A0.082%
5/17/2021 Goldman Sachs Group Inc.12,986$144K0.0%N/A0.082%
5/13/2021 ARK Investment Management LLC476,414$5.28M0.0%N/A3.023%
5/13/2021 Renaissance Technologies LLC290,406$3.22M0.0%+4.0%1.843%
5/12/2021 UBS Group AG10,872$120K0.0%-51.5%0.069%
(Data available from 1/1/2016 forward)

ENLV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ENLV shares?

During the previous two years, the following institutional investors and hedge funds held shares of Enlivex Therapeutics shares: Armistice Capital LLC ($1.73M), Millennium Management LLC ($742K), Renaissance Technologies LLC ($186K), Jane Street Group LLC ($78K), Sigma Investment Counselors Inc. ($50K), and XTX Topco Ltd ($35K), and Two Sigma Securities LLC ($26K).Learn more on ENLV's institutional investors.

What percentage of Enlivex Therapeutics stock is owned by institutional investors?

1.02% of Enlivex Therapeutics stock is owned by institutional investors. Learn more on ENLV's institutional investor holdings.

Which institutional investors have been buying Enlivex Therapeutics stock?

The following institutional investors have purchased Enlivex Therapeutics stock in the last 24 months: Armistice Capital LLC ($1.70M), Millennium Management LLC ($633.85K), Renaissance Technologies LLC ($84.20K), Jane Street Group LLC ($67.89K), Sigma Investment Counselors Inc. ($30K), XTX Topco Ltd ($24.82K), and Two Sigma Securities LLC ($22.36K).

How much institutional buying is happening at Enlivex Therapeutics?

Institutional investors have bought a total of 2,563,689 shares in the last 24 months. This purchase volume represents approximately $3.43M in transactions.

Which Enlivex Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Enlivex Therapeutics stock in the last 24 months: Armistice Capital LLC ($426.07K).

How much institutional selling is happening at Enlivex Therapeutics?

Institutional investors have sold a total of 426,069 shares in the last 24 months. This volume of shares sold represents approximately $413.37K in transactions.



This page (NASDAQ:ENLV) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners